Exchange: NASDAQ·Updated 04:10 PM EST
REVB logo

REVB Revelation Biosciences Inc

$3.56
$0.19
(5.15%)
Today
Closed $3.50
$0.06
(1.71%)
After Hours
Reported EarningsNov 5
Mkt Cap$2.52M
Vol9,790.00

About REVB

Revelation Biosciences, Inc. engages in the development of immunologic-based therapies for the prevention and treatment of disease. Its product candidates include REVTx-99b, its lead therapeutic candidate being developed for allergic rhinitis and chronic nasal congestion, REVDx 501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation, and REVTx 200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. The company was founded on November 20, 2019 and is headquartered in San Diego, CA.
36

Bearish Sentiment

How do you feel about REVB?

Day3
$REVB Strong watch today as a recent R/S low float sympathy play, assuming $NUWE goes bananas. 570k float and no ATMs/equity lines to dilute from.
1
CyrusTrade
$REVB the only right option is to distribute the remaining cash among shareholders and close the shop. The only problem is that shareholder value is inversely proportional to management’s interests.

Advertisement|Remove ads.